NCT03070340View on ClinicalTrials.gov

Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Breast Magnetic Resonance Imaging (MRI)

All women who are scheduled for a post-NAT breast MRI and mammogram will be asked to enroll in the study. The addition of contrast to the FFDM (CEDM) would be the only intervention.

DIAGNOSTIC_TEST

Contrast Enhanced Mammography (CEDM)

All women who are scheduled for a post-NAT breast MRI and mammogram will be asked to enroll in the study. The addition of contrast to the FFDM (CEDM) would be the only intervention.

Trial Locations (5)

10021

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (Consent only), Harrison

11725

Memorial Sloan Kettering Commack (Consent only), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

07645

Memorial Sloan Kettering Bergen (Consent only), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03070340 - Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery | Biotech Hunter | Biotech Hunter